Skip to main content
. 2010 Oct;12(8):509–522. doi: 10.1111/j.1477-2574.2010.00222.x

Table 2.

Overview of reported single cases of malignant transformation of hepatocellular adenomas into hepatocellular carcinomas

Reference Year Age/gener Use and duration of OCs or steroids (years) Number of HCAs and size at time of diagnosis of HCC Time to HCA diagnosis (years)a Interval between diagnosis of HCA and HCC (years) Haemorrhage Resected Outcome
Tesluk and Lawrie26 1981 34/F Yes, 5 Solitary, 16 cm 5 3 Yes Yes Postoperative death after one month

Gordon et al.22 1986 36/F Yes, 14 Solitary, 13 cm 14 3 Yes Yes Disease free

Gyorffy et al.20 1989 53/F Yes, 19 Multiple (3), 12 cm 19 2 No No Tumour-related death after 7 months

Korula et al.195 1991 40/F Yes, 15 Solitary, 6.5 cm 21 None No Yes Disease free

Ferrell196 1993 29/F Yes, 0.5 Solitary, 18 cm 5 None No Yes Disease free

Foster and Bermanb19 1994 56/F Yes, 10 Multiple (3–4) 10 5 No No Tumour-related death after 5 months

Herman et al.197 1994 30/F Yes, 15 15 None No Yes n/a

Herman et al.197 1994 37/F Yes, 20 20 None No Yes n/a

Perret et al.198 1996 24/F Yes, 3 Solitary, 14 cm 3 None No Yes Disease free

Scott et al.199 1996 22/M No Solitary, 6 cm None No Yes Disease free

Ye et al.21 1999 42/F Yes, 25 Multiple (2), 9 cm 25 None Yes Yes Disease free

Larson et al.25 2002 52/M No Solitary, 12 cm 11 Yes Yes Recurrence after 6 years

Chuang et al.17 2002 19/M Yes, 15c 15 None No Yes n/a

Chuang et al.17 2002 46/F No Solitary, 10 cm None No Yes n/a

Ito et al.23 2003 57/F Yes, 1 month Solitary, 10 cm 30 None Yes Yes Disease free

Burri et al.200 2006 40/F Yes, 4.5 Solitary, 6 cm 16 None No Yes Disease free

Colovic et al.27 2007 70/F No Solitary, 11.5 cm None No Yes Disease free

Gorayski et al.18 2008 35/M Yes, 2 Solitary, 9 cm 10 None No Yes Disease free

Kim et al.24 2009 53/M No Solitary, 4.5 cm None Yes Yes Disease free
a

Time to HCA diagnosis since start of oral contraceptive therapy (which may has been discontinued before diagnosis).

b

This case is also enlisted in Table 1.

c

Oral prednisolone.

HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; Ocs, oral contraceptives; –, no data available or not reported.